Which inhaler is best?
Asthma is a common illness associated with significant mortality'. Death is the most serious event, but who would not argue that other measures ofpoor control such as admissions to hospital and time lost from work are unnecessarily high? Yet effective treatment with f2 agonists and corticosteroids is widely available. Further developments in therapy are welcome, but there is considerable scope for better use ofthe currently available drugs, as shown by the experience of many hospital physicians, whose patients 'have previously been prescribed suitable treatment, and only require training in ... how to use it'2. Such training is effective in improving patient's technique3.
Long-term direct application of these drugs to the bronchial mucosa by inhalation provides safety with no loss of efficacy, because inhaled drugs are effective in tiny doses, and are largely free from significant toxic effects4. Thus we should aim for inhaled therapy for almost all asthmatics.
Devices for inhaled therapy are of two sorts, providing drugs either as a mist (metered dose aerosol inhalers, MDIs), or as dry powder (such as the 'Spinhaler' or 'Rotahaler'). In capable hands, both are effective. MDIs require a considerable degree of coordination between activation of the aerosol and inspiration5, whereas powder devices liberate the drug in a separate action from subsequent inspiration. MDIs provide convenience with a greater chance of failure, while the powder devices greater success with a more awkward technique.
Unfortunately, difficulties using inhalers are common, and poor technique is found in both patients and health care personnel6. Attempts to design easier techniques by using different devices, or by attaching them to spacers7, squeezers and whistles have all met with some success8. Many patients, however, still find the use of inhalers testing. This problem is widespread, and has been described in studies in the UK6, North America9 and elsewhere10, in children11 and adults12, and in populations drawn from general practice'3 and hospital medicine14. We teach and supervise the techniques involved less often than we should, and this contributes to less effective treatment'5.
Spacing devices (for example, the 'Nebuhaler', 'Volumatic' and the humble plastic coffee cup16) are refinements ofthe MDI which circumvent the greatest problemcoordinating activation with inspiration. Unfortunately, they are very cumbersome, andpatients cannot easily carry them abound. A number of new developments address these problems. The 'Diskhaler'
(Allen and Hanburys) and the 'Turbohaler' (Astra) are both powder devices which profess an easier technique, and in the relaunched 'Autohaler' (Riker), the patient's inspiration triggers the drug mist automatically'7, albeit with an initially disquieting snap.
Which, then, is the best device? Sadly, none of the current devices, however impressive, satisfies the needs of every patient. Given the range of motor skills to be found among asthmatic patients, it would be surprising ifit were otherwise. I suspect that doctors may unwittingly exacerbate the problem by only selecting devices which they themselves find comfortable, familiar or believe to be 'best'. The requirements of our patients, like their skills, may be very different from our own.
When we come to prescribe an inhaler, patient performance and preference are important considerations. It is my experience that when patients are confident with their device, compliance with therapy is improved, and mastering the skill of that device makes an important contribution to their confidence. New developments, which make inhalers easier to use and teach are very welcome, but their full potential can only be achieved when doctors are familiar with the variety available, and choose wisely. Which drug, however goodi, is ideal for every situation?
Successful inhaled therapy involves deciding upon the correct drug and device, teaching its technique, and following it up with regular supervision. Selecting the best inhaler for each patient requires awareness ofthe available range and matching it to the patient's skills. When confronted with an asthmatic patient, the question we should ask is not 'Which inhaler is best?' but 'Which inhaler is best suited to THIS patient's needs?' The initial effort is well rewarded.
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